Global medical cannabis market projected to reach $33.2 billion by 2027
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 14, 2021
COVID-19 impact and global analysis: Medical cannabis market will inflate at 23.9 percent CAGR by 2028
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• July 12, 2021
Canadian cannabis firm Tilray reports $341 million net loss in last quarter
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• May 31, 2021
Report illustrates $28B billion growth in global legal cannabis market between 2020 and 2024
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• February 15, 2021
Cannabis stocks shift north after Biden’s win
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 15, 2020
Canadian cannabis company purchases U.S. craft-beer maker Sweetwater
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 15, 2020
Cannabis firm Canopy Growth favors NASDAQ over the NYSE
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• November 15, 2020
Canadian cannabis producer Aphria shifts U.S. stock market US listing from NYSE to NASDAQ
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• June 1, 2020
Increasing number of EU-GMP certifications being awarded to Canadian cannabis companies
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 24, 2020
Cannabis cultivation market will soar to $45.4 billion by 2026
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• September 25, 2019
Canadian cannabis company Aphria is capitalizing on Jamaica’s cannabis industry
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• August 21, 2019
FDA chief announces resignation, what will happen to the CBD review?
Bethan Rose Jenkins, Cannabis News Writer/Editorial
• March 22, 2019
Load More Stories